The EAU Research Foundation’s web pages now feature extensive details on the currently running trials and studies.
The downloadable documents are in the PDF format, for convenient distribution and printing. The HORRAD Randomised Phase III Clinical Trial is the most recent addition, and as patient recruitment is still running, its figures will continue to be regularly updated. HORRAD explores the effect on survival of hormonal treatment versus hormonal treatment combined with local external radiotherapy in patients with primary metastatic prostate cancer.
Share this on your favourite network: